1990
DOI: 10.1002/j.1460-2075.1990.tb08187.x
|View full text |Cite
|
Sign up to set email alerts
|

An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.

Abstract: To clarify how the v‐abl oncogene of Abelson murine leukemia virus contributes to lymphoid tumorigenesis, we introduced the gene linked to an immunoglobulin heavy chain enhancer (E mu) into the mouse germline. Although lymphoid development was not detectably affected in young E mu‐v‐abl mice, three transgenic lines shared a high predisposition to develop clonal plasmacytomas that secreted IgA or IgG. The unexpected absence of pre‐B lymphomas suggests that Abelson virus generates such tumors by infecting an ear… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
62
0

Year Published

1990
1990
2010
2010

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 81 publications
(64 citation statements)
references
References 50 publications
2
62
0
Order By: Relevance
“…While some of the spontaneous tumors that were analysed showed an elevated Pim1 expression (6/16), all tumors expressed the c-Myc gene at high levels (16/16) (data not shown). Southern blot analysis indicated that the c-Myc activation in these tumors was not the result of translocation, as observed in most plasmacytomas of the Em-v-Abl mice (Rosenbaum et al, 1990). Injection of tumor cells of three dierent lymphomas into syngeneic hosts caused secondary tumors after a latency of 2 ± 4 weeks.…”
Section: Embmi1 Transgenic Mice Are Predisposed To B and T Cell Lymphmentioning
confidence: 80%
“…While some of the spontaneous tumors that were analysed showed an elevated Pim1 expression (6/16), all tumors expressed the c-Myc gene at high levels (16/16) (data not shown). Southern blot analysis indicated that the c-Myc activation in these tumors was not the result of translocation, as observed in most plasmacytomas of the Em-v-Abl mice (Rosenbaum et al, 1990). Injection of tumor cells of three dierent lymphomas into syngeneic hosts caused secondary tumors after a latency of 2 ± 4 weeks.…”
Section: Embmi1 Transgenic Mice Are Predisposed To B and T Cell Lymphmentioning
confidence: 80%
“…For this purpose, we generated transgenic mice for Zfp521 and crossed them with EHKI DNeo mice. To express Zfp521 in lymphoid cells, Zfp521 complementary DNA with an HA tag (Zfp521HA) was subcloned into EmSV vector, which has been successfully used to express target genes in the lymphoid lineage (Rosenbaum et al, 1990) (Figure 5a). Among several transgenic lines established (EmSV/ Zfp521), mice of a line that expresses Zfp521HA at a high level in lymphoid cells (data not shown) were chosen and crossed with EHKI DNeo mice.…”
Section: Resultsmentioning
confidence: 99%
“…Human myelomas overexpress the tyrosine kinase protein, Abl (23), and a proportion of transgenic mice expressing v-Abl, the oncogene product of the Abelson murine leukemia virus under the control of the Ig heavy chain (E ) enhancer and the SV40 Tag promoter, develop plasmacytomas with age (24,25). C57BL/6 mice are normally relatively resistant to plasmacytoma formation, both in transgenic models and in peritoneal irritant-induced tumor models (26)(27)(28).…”
Section: Mlh Loss Accelerates B-cell Lymphomagenesis In Pfp-deficientmentioning
confidence: 99%